CVS Pharmacy has introduced its 2026 holiday collection, featuring an expanded Joyward™ brand with new gifts, décor, and stocking stuffers. The retailer also launched a Holiday Catalog to simplify gift shopping, offering options by recipient, occasion, and budget, including affordable stocking stuffers under $5. The collection includes sensory toys, beauty products, collectibles, and personalized photo gifts with same-day pickup. CVS provides flexible shopping options through its stores, website, and app, with deals for ExtraCare members, aiming to enhance holiday shopping convenience and joy.
CVS Pharmacy's holiday collection launch provides context for consumer cyclical sector activity on Pluang. For readers following this sector, here is Pluang's market snapshot as of Nov 09, 2026 20:02 WIB: Out of 134 priced US consumer cyclical stocks, 100 rose and 23 fell. Notable movers include Goodyear Tire & Rubber Co (GT) at USD 4.10 with a 1-day change of -5.96% and a typical hold time of 59 days, Somnigroup International Inc. (SGI) at USD 60.99 down 4.96% with a 25-day hold, and ThredUp Inc (TDUP) at USD 1.33 up 3.50% with a 30-day hold time.
Neo Security, Inc. has launched Neoverse, a free AI software intelligence engine that researches and classifies over 4 million AI apps, extensions, and servers to assess their capabilities and security risks. Integrated into Neo's platform, Neoverse ...
AnorTech Inc. completed a $7.55 million share exchange with Nasdaq-listed Greenland Mines, increasing Greenland Mines' ownership in AnorTech to 19.9%. Greenland Mines acquired over 25 million AnorTech shares in exchange for Greenland Mines shares val...
Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...
Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...
